[How should endocarditis following heart valve replacement be treated?].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 18382956)

Published in Dtsch Med Wochenschr on April 01, 2008

Authors

D Horstkotte

Articles by these authors

(truncated to the top 100)

[Prospective study of the incidence, pathogenesis and therapy of spontaneous, by coronary angiography diagnosed coronary artery dissection]. Z Kardiol (1998) 1.77

The importance of secondary mitral valve involvement in primary aortic valve endocarditis; the mitral kissing vegetation. Eur Heart J (2002) 1.61

Increased risk of bacterial endocarditis in inflammatory bowel disease. Am J Med (1992) 1.47

[Recurrent immune thrombocytopenia: a rare complication after contrast medium injection]. Dtsch Med Wochenschr (1995) 1.46

[18th report of the statistics of heart catheter laboratories in Germany. Results of a combined survey by the Committee of Clinical Cardiology and the Interventional Cardiology and Angiology Working Group (for ESC) of the German Society of Cardiology-Heart- and Cardiovascular Research 2001]. Z Kardiol (2002) 1.41

[Acute mitral insufficiency in osteogenesis imperfecta]. Dtsch Med Wochenschr (1994) 1.41

Prosthetic valve endocarditis. Heart (2001) 1.40

[Repeated ingestion with suicidal intent of potentially lethal amounts of thallium]. Dtsch Med Wochenschr (1995) 1.39

[The local lysis therapy of spontaneous renal artery dissection with arterial thrombosis]. Dtsch Med Wochenschr (1992) 1.38

[Prevention of endocarditis 1998--what is reliable?]. Dtsch Med Wochenschr (1998) 1.38

One-year follow-up of percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy in 312 patients: predictors of hemodynamic and clinical response. Clin Res Cardiol (2007) 1.35

[19th report of performance statistics of heart catheterization laboratories in Germany. Results of a collaborative survey by the Committee of Clinical Cardiology and the Interventional Cardiology (for ESC) and Angiology Study Groups of the German Society of Cardiology--Heart and Cardiovascular Research in 2002]. Z Kardiol (2004) 1.31

Guidelines for prevention of thromboembolic events in valvular heart disease. Study Group of the Working Group on Valvular Heart Disease of the European Society of Cardiology. Eur Heart J (1995) 1.21

The Björk-Shiley 70 degree convexo-concave prosthesis strut fracture problem (present state of information). Thorac Cardiovasc Surg (1987) 1.19

[20th report of performance data from heart catheterization laboratories in Germany. 2003 results of a collaborative survey by the Committee of Clinical Cardiology and the Interventional Cardiology (for ECS) and Angiology Study Groups of the German Society of Cardiology-Cardiovascular Research]. Z Kardiol (2005) 1.14

[Epidural spinal cord stimulation for therapy of chronic pain. Summary of the S3 guidelines]. Schmerz (2011) 1.08

Antibiotic prophylaxis for infective endocarditis from an international group of experts towards a European consensus. Group of Experts of the International Society for Chemotherapy. Eur Heart J (1995) 1.03

Stroke is not a contraindication for urgent valve replacement in acute infective endocarditis. J Heart Valve Dis (2001) 1.02

Adaptive servoventilation in diastolic heart failure and Cheyne-Stokes respiration. Eur Respir J (2009) 0.99

Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy. Int J Cardiovasc Imaging (2010) 0.96

Better understanding of the pathogenesis of prosthetic valve endocarditis--recent perspectives for prevention strategies. J Heart Valve Dis (1998) 0.95

[Not Available]. Z Kardiol (2002) 0.93

Multimodality in imaging calcific constrictive pericarditis. Heart (2006) 0.93

[Aortic stenosis]. Clin Res Cardiol (2006) 0.92

[Prevalence of sleep-related breathing disorders in ischemic and non-ischemic heart failure]. Dtsch Med Wochenschr (2007) 0.92

[Analysis of inter- and intraventricular asynchrony by tissue Doppler echocardiography]. Z Kardiol (2003) 0.91

Long-term follow-up of pulmonary hypertension in patients with and without anorectic drug intake. Cor Vasa (1985) 0.91

[Myocardial perfusion under H.E.L.P. -apheresis. Objectification by PET]. Z Kardiol (2003) 0.89

Late complications in patients with Björk-Shiley and St. Jude Medical heart valve replacement. Circulation (1983) 0.89

Catheter-based septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: follow-up results of the TASH-registry of the German Cardiac Society. Z Kardiol (2005) 0.88

Death due to transprosthetic catheterization of a Björk-Shiley prosthesis in the aortic position. Am J Cardiol (1986) 0.88

Prosthetic valve endocarditis: clinical findings and management. Eur Heart J (1984) 0.87

[An increased incidence of bacterial endocarditis in chronic inflammatory bowel diseases]. Z Gastroenterol (1992) 0.86

Diagnostic superiority of a combined assessment of the systolic and early diastolic mitral annular velocities by tissue Doppler imaging for the differentiation of restrictive cardiomyopathy from constrictive pericarditis. Clin Res Cardiol (2010) 0.86

Electrocardiographic remodeling in patients paced for heart failure. Am J Cardiol (2000) 0.85

Echo-guided percutaneous coil embolization of a symptomatic massive metastasis of a renal cell carcinoma in the right ventricular outflow tract. Eur J Echocardiogr (2008) 0.85

Antithrombotic therapy in patients with mechanical and biological prosthetic heart valves. Chest (1998) 0.84

[Acute myocardial infarct caused by a muscle bridge of the anterior interventricular ramus: complicated course with vascular perforation after stent implantation]. Z Kardiol (1997) 0.83

[Effect of prosthetic heart valve replacement on the natural course of isolated mitral and aortic as well as multivalvular diseases. Clinical results in 783 patients up to 8 years following implantation of the Björk-Shiley tilting disc prosthesis]. Z Kardiol (1983) 0.83

[Validation of continuous blood pressure measurements by pulse transit time: a comparison with invasive measurements in a cardiac intensive care unit]. Dtsch Med Wochenschr (2010) 0.81

Cardiorespiratory screening for sleep-disordered breathing. Eur Respir J (2006) 0.81

Atrial fibrillation in carcinoid heart disease: The role of serotonin. A review of the literature. Clin Res Cardiol (2006) 0.80

Five-year results after randomized mitral valve replacement with Björk-Shiley. Lillehei-Kaster, and Starr-Edwards prostheses. Thorac Cardiovasc Surg (1983) 0.80

Right atrial hemangioma in modern cardiac imaging. Clin Res Cardiol (2006) 0.80

Radiation protection during cardiac catherization: development of an improved lead apron for periinterventional echocardiography. Minerva Cardioangiol (2015) 0.80

Reoperations for malfunction of heart valve prostheses, especially with endocarditis. Thorac Cardiovasc Surg (1987) 0.79

[Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy]. Z Kardiol (2003) 0.79

Intra-individual head-to-head comparison of Sirolimus®- and Paclitaxel®-eluting stents for coronary revascularization. A randomized, multi-center trial. Int J Cardiol (2012) 0.79

Lipid apheresis: oxidative stress, rheology, and vasodilatation. Clin Res Cardiol Suppl (2012) 0.79

[Benefits of endocarditis prevention in patients with prosthetic heart valves]. Z Kardiol (1986) 0.79

[Recommendations for prevention of thromboembolism in heart valve diseases. Working Group on Valvular Heart Disease, European Society of Cardiology]. Z Kardiol (1995) 0.79

[S2 guideline for infectious endocarditis]. MMW Fortschr Med (2004) 0.79

Hypertrophic cardiomyopathy in cardiac CT: a validation study on the detection of intramyocardial fibrosis in consecutive patients. Int J Cardiovasc Imaging (2014) 0.78

Potential flaws in the assessment of minor cerebrovascular events after heart valve replacement. J Heart Valve Dis (1993) 0.78

Is myocardial Na+/Ca2+ exchanger transcription a marker for different stages of myocardial dysfunction? Quantitative polymerase chain reaction of the messenger RNA in endomyocardial biopsies of patients with heart failure. J Am Coll Cardiol (2000) 0.78

[H.E.L.P. apheresis and oxidative stress]. Z Kardiol (2003) 0.78

[Optimal management of primary and secondary mitral regurgitation]. Herz (1998) 0.77

[PTCA in the acute state of myocardial infarct: hospital course of 785 consecutive patients]. Z Kardiol (1994) 0.77

Screening for sleep-disordered breathing is recommended in patients with chronic heart failure. Eur Respir J (2007) 0.77

[Acute coronary artery occlusion after elective percutaneous transluminal coronary angioplasty. Incidence and therapy in 5000 consecutive patients]. Dtsch Med Wochenschr (1994) 0.77

[Detection and therapy of respiratory dysfunction by implantable (cardiac) devices]. Herz (2014) 0.77

Left ventricular mass and oxygen uptake in top handball athletes. Int J Sports Med (2012) 0.77

[Non-surgical management of a perforated left anterior descending coronary artery following cardiopulmonary resuscitation]. Z Kardiol (1999) 0.77

[Long-term follow-up after percutaneous septal ablation in hypertrophic obstructive cardiomyopathy ]. Dtsch Med Wochenschr (2008) 0.77

Patch-graft enlargement of the aortic root using autologous pericardium (long-term results). Thorac Cardiovasc Surg (1983) 0.77

[21st report about the statistics of the heart catheterization laboratory in the German Federal Republic. Results of the joint inquiry of the Commission for Clinical Cardiology and of the Working Groups for Interventional Cardiology and Angiology of the German Society for Cardiology and Circulatory Research in the year 2004]. Clin Res Cardiol (2006) 0.77

[Sleep disordered breathing and cardiac arrhythmias: mechanisms, interactions, and clinical relevance]. Dtsch Med Wochenschr (2011) 0.77

[Left ventricular pacing and CRT. What CV lead fits into which vein?]. Herzschrittmacherther Elektrophysiol (2006) 0.76

[Home monitoring of patients after prosthetic valve replacement-a new method of early detection of valve dysfunction]. Z Kardiol (2004) 0.76

Thrombosis of two St. Jude Medical prostheses in one patient after triple valve replacement. Case report and review of the literature. Eur J Cardiothorac Surg (1988) 0.76

[The Lyme carditis as a rare differential diagnosis to an anterior myocardial infarction]. Z Kardiol (2002) 0.76

[Sleep-disordered breathing and cardiac arrhythmias]. Herzschrittmacherther Elektrophysiol (2012) 0.76

[Lipoprotein(a): influence on cardiovascular manifestation]. Clin Res Cardiol Suppl (2015) 0.76

[Systemic Nocardia asteroides infection with endocardial involvement in a patient undergoing immunosuppressive therapy]. Dtsch Med Wochenschr (1996) 0.76

[Constrictive pericarditis or restrictive cardiomyopathy? Echocardiographic tissue Doppler analysis]. Dtsch Med Wochenschr (2008) 0.75

[Sleep-related breathing disorders and (resulting) cardiovascular diseases]. Herz (2014) 0.75

[17th report of performance statistics of heart catheterization laboratories in Germany. Results of a combined survey by the Committee of Clinical Cardiology and the Interventional Cardiology (for ESC) and Angiology Working Groups of the German Society of Cardiology-Cardiovascular Research for the year 2000]. Z Kardiol (2001) 0.75

Results with mechanical cardiac valvular prostheses. Ann Thorac Surg (1996) 0.75

Problems with complication rate analysis. J Thorac Cardiovasc Surg (2003) 0.75

[The intensive medical treatment of severe malaria tropica]. Dtsch Med Wochenschr (1991) 0.75

[Is Na+Ca(2+) exchanger expression altered in the endomyocardium of patients with chronic heart valve diseases parallel to myocardial dysfunction?]. Z Kardiol (2000) 0.75

Thromboembolic complications following heart valve replacement: the role of patient-related coagulability. J Heart Valve Dis (1998) 0.75

Cardiac re-synchronization therapy: effects on myocardial perfusion at rest, after vasodilation and oxygen consumption. Nuklearmedizin (2006) 0.75

Central hemodynamics at rest and during exercise after mitral valve replacement with different prostheses. Circulation (1983) 0.75

[Prosthesis endocarditis with embolization of a Smeloff-Cutter aortic valve prosthesis. Diagnosis, surgical management, clinical and hemodynamic course to 3 years' postoperative follow-up]. Z Kardiol (1983) 0.75

[Hemolysis after Björk-Shiley, Lillehei-Kaster and Starr-Edwards mitral valve prosthesis]. Verh Dtsch Ges Inn Med (1978) 0.75

Preliminary results in mitral valve replacement with St. Jude medical prosthesis: comparison with the Björk-Shiley valve. Circulation (1981) 0.75

[Hemodynamic findings at rest and during exercise following implantation of different mitral valve prostheses with equal tissue annulus diameter]. Z Kardiol (1983) 0.75

[Effect of valve type and valve function on chronic intravascular hemolysis after alloprosthetic mitral and aortic valve replacement]. Z Kardiol (1983) 0.75

[Clinical, morphological and biochemical findings in the Kearns-Sayre syndrome]. Fortschr Ophthalmol (1983) 0.75

[Echocardiographic assessment of left ventricular size and function in patients before and after aortic valve replacement (author's transl)]. Z Kardiol (1981) 0.75

[Cardiac valve replacement and simultaneous myocardial revascularization]. Z Kardiol (1983) 0.75

[Therapy and prevention of infectious endocarditis]. Schweiz Med Wochenschr (1984) 0.75

[Hemodynamic rest and stress studies following implantation of various aortic valve prostheses]. Z Kardiol (1983) 0.75

Mitral valve replacement using different prosthetic valves. Int J Artif Organs (1982) 0.75

Bacteriological assistance for optimal antibiotic therapy of endocarditis. Eur Heart J (1984) 0.75

Coronary vein leads for cardiac pacing in patients with tricuspid valve replacement. Thorac Cardiovasc Surg (2002) 0.75

[Reoperation following correction of partial defects of the endocardial cushion (indication, incidence, results)]. Z Kardiol (1984) 0.75

Preliminary clinical and hemodynamic results after mitral valve replacement using St. Jude Medical prostheses in comparison with the Björk-Shiley valve. Thorac Cardiovasc Surg (1981) 0.75

[Late complications following Björk-Shiley and St. Jude Medical heart valve replacement]. Z Kardiol (1983) 0.75